Jonathan Eze writes that Fidson Healthcare Plc is currently championing a progressive pathway for the pharmaceutical industry
The demand for quality and affordable healthcare solutions for this population puts great pressure on available resources – requiring improvements and upgrades. This has spurred investment in local production of pharmaceuticals with the aim of promoting self-sufficiency and national security for medicines. Existing pharmaceutical companies are also developing local industrial capacity with a global standard in a view to earning foreign exchange through exportation of domestically manufactured medicines and of course creating new jobs.
The manufacturing plant includes facilities for seven production lines: eye and ear drops, intravenous fluids, tablets, capsules, liquids, cream/ointments, and dry powder. He also noted that with the factory’s potential being harnessed, the company is assured of a competitive edge that will not only see it deliver better quality and more affordable medicines, it will also generate more employment, increase local content, foster stronger local and international partnerships, as well as consolidate the company’s strategic brand and market positioning.
“The company is also taking advantage of the attractive industry dynamics to position itself for sustainable growth, particularly with the growing prevalence of lifestyle diseases amongst Nigeria’s large and increasingly urbanised population.